All reports

Pharmacogenetic tests in Belgium

KCE Reports 382C (2024)Pharmacogenetic tests aim to determine how a patient's DNA can influence the effect of certain medications, in order to refine the choice of therapy or its dosage. KCE has assessed the way these tests are currently used in Belgium. It concludes the conditions for the effective use of pharmacogenetic tests are currently not sufficiently met, and a consensus on the clinical usefulness of some tests sometimes appears to be lacking.

The use of whole genome sequencing in clinical practice: challenges and organisational considerations for Belgium

KCE Reports 300C (2018) The sequencing of the entire genome is a new form of genetic testing which, instead of targeting certain isolated genes, decodes all of an individual’s genes all at once (= his or her genome). This technology is advancing rapidly and its costs are decreasing, which suggests that it could soon displace conventional testing.

Oncogenetic testing for persons with hereditary endocrine cancer syndromes

KCE Reports 242 (2015)Please take note of the publication date of this guideline. From a methodological point of view, a guideline is generally considered obsolete after 5 years. It is therefore possible that some parts of this document are no longer relevant.

Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2

KCE Reports 243C (2015)Please take note of the publication date of this guideline. From a methodological point of view, a guideline is generally considered obsolete after 5 years. It is therefore possible that some parts of this document are no longer relevant.

All reports

6 results

Pharmacogenetic tests in Belgium

The use of whole genome sequencing in clinical practice: challenges and organisational considerations for Belgium

Oncogenetic testing for persons with hereditary endocrine cancer syndromes

Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2

Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li Fraumeni syndrome and Cowden syndrome

Oncogenetic testing for Lynch syndrome and familial adenomatous polyposis

You are here

All reports

General domain

Publication year

Results

6 results

Pharmacogenetic tests in Belgium

The use of whole genome sequencing in clinical practice: challenges and organisational considerations for Belgium

Oncogenetic testing for persons with hereditary endocrine cancer syndromes

Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2

Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li Fraumeni syndrome and Cowden syndrome

Oncogenetic testing for Lynch syndrome and familial adenomatous polyposis